Mike J. Callaghan

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA

Catamaran Corp. provided pharmacy benefits management services. The company was founded on March 19, 1993 and headquartered in Schaumburg, IL.

Saints Ventures LLC (Saints Ventures) is a private equity/venture capital firm founded in 2000 by Ken Sawyer and David Quinlivan. The firm is headquartered in Denver, Colorado.

Founded in 2009, Ernst & Young Capital Advisors LLC is an SEC-registered broker/dealer headquartered in Chicago, Illinois. The firm is affiliated with Ernst & Young LLP. Ernst & Young Capital Advisors provides an array of trading and execution services for their clients. They do not provide any internal research.

Biosurface Engineering Technologies, Inc. was a holding company, which engaged in the development of proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. It offered amplex and soft tissue augmentation services. The company was founded by Thomas G. Roueche, Paul O. Zamora, William G. Mavity, and Linda M. Finn in 2001 and was headquartered in Rockville, MD.